Evoke Pharma
EVOK
EVOK
19 hedge funds and large institutions have $6.17M invested in Evoke Pharma in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
24% less funds holding
Funds holding: 25 → 19 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
19
Holding in Top 10
–
Calls
$745K
Puts
$19K
Top Buyers
| 1 | +$367K | |
| 2 | +$163K | |
| 3 | +$83.9K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$65K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$54K |
Top Sellers
| 1 | -$193K | |
| 2 | -$183K | |
| 3 | -$67K | |
| 4 |
Jane Street
New York
|
-$33K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$26K |